Increasing demand for economical cold chain solutions for the last-mile reach of vaccines
Vaccines are one of the most significant successes in world health and development. Vaccines have successfully decreased the scourge of diseases like polio, measles and smallpox for over two centuries, allowing children to grow healthy and happy. According to UNICEF, even before COVID-19 arrived, they saved more than five lives every minute, averting up to three million fatalities each year.
Children can walk, play and learn thanks to global immunization initiatives. Vaccinated children perform better in school, resulting in economic benefits for their communities. Vaccines are now considered one of the most cost-effective ways to improve global welfare.
However, improper and incompetency of vaccine supply for the last-mile reach is one of the top threats to public health. According to UNICEF, some 20 million children miss out on life-saving vaccines annually. The poorest and marginalized children often most need vaccines continue to be the least likely to get them. Therefore, UNICEF and their partners harness solar power, mobile technology and telemetrics to assure vaccines reach all children without losing their effectiveness from vulnerability to extreme heat or cold weather conditions.
Utilizing isothermal boxes for the vaccine is required to increment quickly in the interest of efficient virus chain answers for the last-mile reach of antibodies.
A solitary well-being specialist can convey isothermal boxes for the vaccine, particularly antibody transporters, by walking or a bike to an effort meeting because of their small size. Moreover, isothermal antibodies are also used to move immunizations from essential medical care habitats to transitional immunizations stores.
The need for temperature-controlled thermal shippers to distribute high-quality COVID-19 vaccines across the world
The storage of the COVID-19 vaccine depends on the temperature they need to be kept at for their potency to remain intact. It varies with each vaccine candidate, even if they are developed using the same technology. The vaccines require a special packaging and storage facility, a cold chain storage system to keep the vaccine efficient.
In November 2020, Pfizer developed a special transport box the size of a suitcase, packed with dry ice and installed with GPS trackers. Each reusable box can keep up to 5,000 doses of the vaccine at the required temperature for ten days if it remains unopened. In addition, Wiltshire-based firm Polar Thermals makes similar boxes for other vaccines and counts Pfizer among its clients.
Moreover, In March 2021, Pluss Advanced Technologies, an India-based material solutions company that designs isothermal boxes for vaccine transportation, received a patent from U.S. Patent and Trademark Office for its box named Celsure.
Besides, in November 2020, Narendra Modi, The PM of India, took up his counterpart's offer in Luxembourg, Xavier Bettel, to set up a specialized refrigerated vaccine transportation plant in Gujarat to ensure last mile drug delivery to villages all over the country. The refrigerated transport boxes can deliver vaccines between four degrees Celsius to 20 below zero.
The refrigerated boxes would be powered by solar, kerosene, gas and electricity. The B Medical Systems company will set up a full-fledged plant in Gujarat in phase II for not only supplying to Indian requirement but also exporting it to other countries.
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Website: www.datamintelligence.com
